Viewing Study NCT07308392

Home

Certify Doc

Genes

Clinical Trials

CompTox

DrugMatrix

Open Targets

Products

Support

Bugs

Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug

Ignite Creation Date: 2026-03-26 @ 3:15 PM

Ignite Modification Date: 2026-03-31 @ 4:06 AM

Study NCT ID: NCT07308392

Status: RECRUITING

Last Update Posted: 2026-03-03

First Post: 2025-12-15

Is NOT Gene Therapy: True

Has Adverse Events: False

Brief Title: Phase II Clinical Trial Evaluating the Efficacy and Safety of HRS-7249 and SHR-1918 in Patients With Severe Hypertriglyceridemia at High Risk of Acute Pancreatitis

Sponsor: Fujian Shengdi Pharmaceutical Co., Ltd.

Organization:

Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module